Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antitumor agent disclosed in patent literature by Taisho

July 1, 1998

Phase I trial results for AG-2034 presented at NCI-EORTC symposium

July 1, 1998

DPPE proves highly effective and well tolerated in metastatic breast cancer patients

June 30, 1998

No dose-limiting toxicity found yet for AN-9 in phase I

June 30, 1998

Inhibitors of Ras function patented by Schering-Plough

June 30, 1998

University of British Columbia awarded grant to study vanadium compounds

June 30, 1998

Parke-Davis discusses development of potent, irreversible EGF receptor TK inhibitors

June 30, 1998

Oxidized phenolic compounds with an unexpected mechanism of action

June 30, 1998

U.S. patent licensed to Avax Technologies issued for anticancer compounds

June 30, 1998

Various schedules and doses of DMDC explored in phase I

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...